You just read:

John Theurer Cancer Center part of multi-center study with National Cancer Institute and Kite Pharma for CAR-T Cell Therapy Study Showing Very Impressive Results in Aggressive Lymphoma Refractory to Chemotherapy

News provided by

Hackensack Meridian Health

Mar 06, 2017, 09:28 ET